NDPS Act: Limited 2026 Updates Signal Regulatory Stability
Recent searches reveal minimal NDPS notifications in Q1 2026, while related pharmaceutical regulations show active enforcement. Key compliance insights.
Regulatory Updates
Regulatory Updates
CDSCO New 2026 Rules: Application Rejections & IVD Import Guide
CDSCO threatens rejection of 2+ year pending applications by Feb 14, 2026. New IVD import guidance and cosmetic enforcement actions reshape compliance.
CDSCO Circular (23–24 February 2026)
Key highlights from the CDSCO circular on “Testing of drugs for grant of permissions for import/manufacture of New Drug for sale or for distribution and
Highlights of CDSCO Notification dated 16.02.2026
G.S.R. 135(E) – Changes to the Drugs Rules On February 16, 2026, the Central Drugs Standard Control Organization (CDSCO) rolled out Notification G.S.R. 135(E), bringing
Trusted Regulatory Consultants in India for Business Compliance
Let’s be real: in today’s business world, you can’t just ignore compliance. It’s not a box to tick—it’s something you’ve got to nail if you
ACPL
Highlights and benefits of the recent U.S.–India trade agreement-Accredited Consultant Private Limited
Highlights and benefits of the recent U.S.–India trade agreement, with a focus on what it does (including tariff reductions) and why it matters — drawing
ACPL
India–EU Free Trade Agreement: What It Means for Business
India-EU Free Trade Agreement — The “Mother of All Deals” Big news on the trade front: On January 27, 2026, India and the European Union
BIS Registration Consultant Noida
Noida’s business scene is changing fast, and if you want your products to hit the market without hiccups, you need to meet the Bureau of